The page is the record's research on the issuer — no analyst, no rating, no view. # Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing Kiniksa Pharmaceuticals International, plc is listed on NASDAQ under the ticker KNSA, with ISIN USG526941095. The LEI is not on the record, because no GLEIF record with the exact legal name in jurisdiction US exists. The security type is Corporate, the sector is 2834 Pharmaceutical Preparations, the segment and jurisdiction are not on the record, and the listing status is listed, not halted. ## The disclosure read The record holds 103 filings in the window from 2025-11-08 to 2026-11-08, on 51 filing days. The median gap between filing days is 3.0 days, and the latest filing is 2 days before the record date of 2026-11-08. Its latest filing is of type directors_dealings, dated 2026-11-06. The NASDAQ median is 52 filings, a median cadence gap of 6.0 days and a median latency of 5.0 days. The sector median for 2834 Pharmaceutical Preparations is 63.0 filings, a median cadence gap of 6.0 days and a median latency of 4.0 days. The issuer's filings are 58 directors_dealings, 29 regulatory_filing, 9 results, 3 agm_egm, 3 director_change and 1 corporate_news. ## Auditor The auditor is not on the record, because the latest annual report cover carries no dei:AuditorName tag. The auditor's location is not on the record, and the record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable, because the chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for this issuer. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001730430.json (identity.name) - https://mcp.us-cm-kg.ai/events/NASDAQ/KNSA (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/KNSA (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/KNSA · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp